[淋巴肉芽肿病的放疗]。

Strahlentherapie Pub Date : 1985-04-01

K H Hübener

{"title":"[淋巴肉芽肿病的放疗]。","authors":"K H Hübener","doi":"","DOIUrl":null,"url":null,"abstract":"The status of radiotherapy of Hodgkin's disease is no longer determined by the staging alone but also by some special risk factors. So a marked improvement of curative radiotherapy becomes possible by close co-operation with chemotherapy, above all in patients with Bulky disease or with constellations having hitherto a considerably deteriorated prognosis in case of exclusive application of radiotherapy. The present study describes the different risk factors and submits the modified therapeutic procedure depending on the different stages.","PeriodicalId":21981,"journal":{"name":"Strahlentherapie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1985-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Radiotherapy of lymphogranulomatosis].\",\"authors\":\"K H Hübener\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The status of radiotherapy of Hodgkin's disease is no longer determined by the staging alone but also by some special risk factors. So a marked improvement of curative radiotherapy becomes possible by close co-operation with chemotherapy, above all in patients with Bulky disease or with constellations having hitherto a considerably deteriorated prognosis in case of exclusive application of radiotherapy. The present study describes the different risk factors and submits the modified therapeutic procedure depending on the different stages.\",\"PeriodicalId\":21981,\"journal\":{\"name\":\"Strahlentherapie\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1985-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Strahlentherapie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Strahlentherapie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

何杰金氏病的放疗地位已不再仅由分期决定，而是由一些特殊的危险因素决定。因此，通过与化疗的密切合作，治疗性放射治疗的显著改善成为可能，特别是对于那些患有大体积疾病或在单独应用放射治疗的情况下预后严重恶化的星座患者。本研究描述了不同的危险因素，并根据不同的阶段提出了相应的治疗方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[Radiotherapy of lymphogranulomatosis].

The status of radiotherapy of Hodgkin's disease is no longer determined by the staging alone but also by some special risk factors. So a marked improvement of curative radiotherapy becomes possible by close co-operation with chemotherapy, above all in patients with Bulky disease or with constellations having hitherto a considerably deteriorated prognosis in case of exclusive application of radiotherapy. The present study describes the different risk factors and submits the modified therapeutic procedure depending on the different stages.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Strahlentherapie

自引率

0.00%

发文量

期刊最新文献

Proton therapy at Harvard. Proton radiotherapy with the Uppsala cyclotron. Experience and plans. Neutron radiobiology and clinical consequences. Review and evolution of clinical results in the EORTC Heavy-Particle Therapy Group. Results of curative pion therapy at SIN.